Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct 8;167(18):1922-9.
doi: 10.1001/archinte.167.18.1922.

Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review

Jordan Dimitrakov  1 , Kurt Kroenke, William D Steers, Charles Berde, David Zurakowski, Michael R Freeman, Jeffrey L Jackson
Affiliations

Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review

Jordan Dimitrakov et al. Arch Intern Med. .

Erratum in

  • Arch Intern Med. 2007 Dec 10-22;167(22):2452

Abstract

Background: More than 180 different types of therapy have been used in the treatment and management of painful bladder syndrome/interstitial cystitis (PBS/IC), yet evidence from clinical trials remains inconclusive. This study aimed to evaluate the efficacy of pharmacologic approaches to PBS/IC, to quantify the effect size from randomized controlled trials, and to begin to inform a clinical consensus of treatment efficacy for PBS/IC.

Methods: We identified randomized controlled trials for the pharmacologic treatment of patients with PBS/IC diagnosed on the basis of National Institute of Diabetes and Digestive and Kidney Diseases or operational criteria. Study limitations include considerable patient heterogeneity as well as variability in the definition of symptoms and in outcome assessment.

Results: We included a total of 1470 adult patients from 21 randomized controlled trials. Only trials for pentosan polysulfate sodium had sufficient numbers to allow a pooled analysis of effect. According to a random-effects model, the pooled estimate of the effect of pentosan polysulfate therapy suggested benefit, with a relative risk of 1.78 for patient-reported improvement in symptoms (95% confidence interval, 1.34-2.35). This result was not heterogeneous (P = .47) and was without evidence of publication bias (P = .18). Current evidence also suggests the efficacy of dimethyl sulfoxide and amitryptyline therapy. Hydroxyzine, intravesical bacille Calmette-Guérin, and resiniferatoxin therapy failed to demonstrate efficacy, but evidence was inconclusive owing to methodological limitations.

Conclusions: Pentosan polysulfate may be modestly beneficial for symptoms of PBS/IC. There is insufficient evidence for other pharmacologic treatments. A consensus on standardized outcome measures is urgently needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect on Patient-Reported Pain
Figure 2
Figure 2
Effect on Patient-Reported Frequency
Figure 3
Figure 3
Effect on Patient-Reported Urgency
Figure 4
Figure 4
Effect on Patient-Reported O’Leary IC Symptom Index
Figure 5
Figure 5
Relative Risk of Overall Improvement with PPS treatment
See this image and copyright information in PMC

References

    1. Vaughan E, Wilt T, Hanno P, Curhan GC. National Institutes of Diabetes and Digestive and Kidney Diseases/National Institutes of Health. Bethesda, MD: 2003. [Accessed February 26, 2007]. Interstitial Cystitis Epidemiology Task Force Meeting Executive Committee Summary. Available at http://www.niddk.nih.gov/fund/reports/ic/executive_summary.htm.
    1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37–49. - PubMed
    1. Hunner GL. A rare type of bladder ulcer in women; report of cases. Boston Med Surg Journal. 1915;172:660–664.
    1. Messing EM, Stamey TA. Interstitial cystitis: early diagnosis, pathology, and treatment. Urology. 1978;12:381–92. - PubMed
    1. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol. 1988;140:203–6. - PubMed

Publication types

Substances